Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

WaveDancer And 1 Other Stock Under $2 Insiders Are Aggressively Buying

Published 10/10/2022, 12:24
Updated 10/10/2022, 13:10
© Reuters.  WaveDancer And 1 Other Stock Under $2 Insiders Are Aggressively Buying
ALZN
-

The Dow Jones dropped by more than 600 points on Friday. Investors, meanwhile, focused on some notable insider trades.

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.3

WaveDancer

  • The Trade: WaveDancer, Inc. (NASDAQ: WAVD) CEO James Gerald Benoit Jr bought a total of 9,500 shares at an average price of $1.06. To acquire these shares, it cost around $10.07 thousand.
  • What’s Happening: WaveDancer, during August, posted Q2 sales of $4.30 million.
  • What WaveDancer Does: WaveDancer Inc, formerly Information Analysis Inc is in the business of developing and maintaining information technology systems, modernizing client information systems, and performing professional services to government and commercial organizations.
  • The Trade: Alzamend Neuro, Inc. (NASDAQ: ALZN) 10% owner Milton C. Ault III acquired a total of 1,000 shares at an average price of $1.43. The insider spent around $1.43 thousand to buy those shares.
  • What’s Happening: Alzamend Neuro recently dosed its first healthy adult subject in its Phase 2A multiple ascending dose (MAD) study of AL001 in subjects with dementia related to Alzheimer's.
  • What Alzamend Neuro Does: Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Don’t forget to check out our premarket coverage here .

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.